PHARMA: UBS picks 2 pharma shares which can be probably to offer 23-26% returns
Brokerage UBS prefers Solar Pharma and Cipla amongst Indian drugmakers and expects the shares to return 26% and 23%, respectively,...
UBS
UBS Area and the New York Islanders Strike A Sponsorship Deal With JetBlue
UBS Area at Belmont Park BELMONT PARK, NY (CelebrityAccess) — UBS Area and...
UBS backs $37 million spherical for local weather fintech startup Doconomy
From left to proper: Johan Pihl, Doconomy's chief inventive officer and co-founder, and Mathias Wikstrom, chief govt officer and co-founder.DoconomySwedish...
